Validity of high intensive focused ultrasound in the treatment of uterus myoma and adenomyoma in Hebei Province: a report of 166 cases

Abstract

To explore the validity of high intensive focused ultrasound (HIFU) in the treatment of uterus myoma and adenomyoma. A total of 166 patients with uterus myoma and adenomyoma received HIFU treatment from July 2011 to November 2013 at our hospital. The follow-ups were conducted at 1, 3, 6 month post-treatment. Their status of clinical symptoms, tumor volume, blood flow and efficacy of HIFU were evaluated. Menstrual blood decreased after treatment. The levels of hemoglobin all returned to normal in anemic patients and dysmenorrhea showed great improvement. Ultrasound showed that uterine ablation lesions significantly diminished after treatment. The effective rate was 71.8% at 1 month, 86.1% at 3 month and 95.4% at 6 month post-treatment and blood flow within ablation lesions decreased after treatment. None of unacceptable side effects occurred. HIFU treatment of uterus myoma and adenomyoma is both feasible and safe with fewer side effects.